University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Maxwell V. Meng, MD

Maxwell V. Meng, MD

Associate Professor, Department of Urology, UCSF

Cancer Center Program Memberships

Prostate Cancer

Education

A, 1991, Biochemical Sciences, Harvard College, Cambridge, MA
MD, 1995, Medicine, Johns Hopkins School of Medicine, Baltimore, MD
General surgery & urology, UCSF, 1995-2001
Laparoscopic fellowship, UCSF, 2001-2002
Oncology fellowship, UCSF, 2002-2003


Professional Experience

  • 2001-2003
    Clinical Instructor, Dept. of Urology, UCSF
  • 2001-present
    Attending Surgeon, San Francisco Veterans Hospital
  • 2001-present
    Attending Surgeon, San Francisco General Hospital
  • 2003-2007
    Assistant Professor in Residence, Dept. of Urology, UCSF
  • 2007-present
    Associate Professor in Residence, Dept. of Urology, UCSF

Honors & Awards

  • 1987
    Westinghouse Science Talent Search, 7th Place
  • 1991
    Magna cum laude, Harvard College
  • 1995
    Alpha Omega Alpha, Johns Hopkins
  • 1999
    Third Prize, Northern California Urology Residents Seminar
  • 1999
    Pfizer Scholar in Urology
  • 2001
    Joseph F. McCarthy Essay Contest, 3rd Place, Western Section AUA
  • 2002
    Prostate Cancer Research Fellow
  • 2004
    William R. Smart Distinguished Teaching Award (selected by residents)
  • 2005
    Excellence in Direct Teaching, Academy of Medical Educators, UCSF
  • 2006
    Ambrose/Reed Socioeconomic Prize Essay (AUA)
  • 2006
    AUA leadership Program (1 of 16 selected nationally biennially)
  • 2006
    Miley B. Wesson Essay Contest, 2nd Place, AUA

Selected Publications

  1. Washington SL, Neuhaus J, Meng MV, Porten SP. Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder Cancer. Cancer Epidemiol Biomarkers Prev. 2019 Aug; 28(8):1339-1344.
    View on PubMed
  2. Herlemann A, Meng MV. Editorial: Conversion to negative surgical margin after intraoperative frozen section - (un)necessary effort and relevance in 2019? BJU Int. 2019 May; 123(5):744-746.
    View on PubMed
  3. Meng MV, Gschwend JE, Shore N, Grossfeld GD, Mostafid H, Black PC. Emerging Immunotherapy Options for Bacillus Calmette-Guérin Unresponsive Nonmuscle Invasive Bladder Cancer. J Urol. 2019 May 01; 101097JU0000000000000297.
    View on PubMed
  4. Balakrishnan AS, Washington SL, Meng MV, Porten SP. Determinants of Guideline-Based Treatment in Patients With cT1 Bladder Cancer. Clin Genitourin Cancer. 2019 Jun; 17(3):e461-e471.
    View on PubMed
  5. Hampson LA, Odisho AY, Meng MV. Variation in Laparoscopic Nephrectomy Surgical Costs: Opportunities for High Value Care Delivery. Urol Pract. 2018 Sep; 5(5):334-341.
    View on PubMed
  6. Schmidt B, Meng MV, Hampson LA. Operating Room Supply Cost Awareness: A Cross-Sectional Analysis. Urol Pract. 2019 Mar; 6(2):73-78.
    View on PubMed
  7. Hussein AA, Sexton KJ, May PR, Meng MV, Hosseini A, Eun DD, Daneshmand S, Bochner BH, Peabody JO, Abaza R, Skinner EC, Hautmann RE, Guru KA. Development and validation of surgical training tool: cystectomy assessment and surgical evaluation (CASE) for robot-assisted radical cystectomy for men. Surg Endosc. 2018 11; 32(11):4458-4464.
    View on PubMed
  8. Sanford T, Meng MV, Railkar R, Agarwal PK, Porten SP. Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma. Clin Epigenetics. 2018; 10:19.
    View on PubMed
  9. Wallace E, Higuchi R, Satya M, McCann L, Sin MLY, Bridge JA, Wei H, Zhang J, Wong E, Hiar A, Mach KE, Scherr D, Egerdie RB, Ohta S, Sexton WJ, Meng MV, Weizer AZ, Woods M, Jansz GK, Zadra J, Lotan Y, Goldfarb B, Liao JC. Development of a 90-Minute Integrated Noninvasive Urinary Assay for Bladder Cancer Detection. J Urol. 2018 03; 199(3):655-662.
    View on PubMed
  10. Welty CJ, Sanford TH, Wright JL, Carroll PR, Cooperberg MR, Meng MV, Porten SP. The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy. Cancer. 2017 Dec 01; 123(23):4574-4582.
    View on PubMed
  11. Liss MA, Ehdaie B, Loeb S, Meng MV, Raman JD, Spears V, Stroup SP. An Update of the American Urological Association White Paper on the Prevention and Treatment of the More Common Complications Related to Prostate Biopsy. J Urol. 2017 08; 198(2):329-334.
    View on PubMed
  12. Meng M. Clin Cancer Res. 2004 Sep 15; 10(18 Pt 2):6371S-6376S. Urol Oncol. 2017 May; 35(5):313-314.
    View on PubMed
  13. Meng M. Frozen section during partial nephrectomy: Does it predict positive margins? Gordetsky J, Gorin MA, Canner J, Ball MW, Pierorazio PM, Allaf ME, Epstein JI. BJU Int. 2015 Dec; 116(6):868-72. [Epub 2015 Mar 23]. doi: 10.1111/bju.13011. Urol Oncol. 2017 05; 35(5):312-313.
    View on PubMed
  14. Meng M. Laparoscopic cryoablation for renal cell carcinoma: 100-Month oncologic outcomes. Caputo PA, Ramirez D, Zargar H, Akca O, Andrade HS, O'Malley C, Remer EM, Kaouk JH. J Urol. 2015 Oct;194(4):892-896. [Epub 2015 April 23]. doi: 10.1016/j.juro.2015.03.128. Urol Oncol. 2017 05; 35(5):311-312.
    View on PubMed
  15. Meng M. Urologic Oncologic SurveyRobotic level III inferior vena cava tumor thrombectomy: Initial series. Gill IS, Metcalfe C, Abreu A, Duddalwar V, Chopra S, Cunningham M, Thangathurai D, Ukimura O, Satkunasivam R, Hung A, Papalia R, Aron M, Desai M, Gallucci M. J Urol. 2015 Oct;194(4):929-938. [Epub 2015 Apr 6]. doi: 10.1016/j.juro.2015.03.119. Urol Oncol. 2017 05; 35(5):311.
    View on PubMed
  16. Hampson LA, Odisho AY, Meng MV, Carroll PR. Variation and Predictors of Surgical Case Costs among Urologists. Urol Pract. 2017 Jul; 4(4):277-284.
    View on PubMed
  17. Garcia MM, Gottschalk AR, Brajtbord J, Konety BR, Meng MV, Roach M, Carroll PR. Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes. PLoS One. 2016; 11(10):e0164558.
    View on PubMed
  18. Nguyen HG, Punnen S, Cowan JE, Leapman M, Cary C, Welty C, Weinberg V, Cooperberg MR, Meng MV, Greene KL, Garcia M, Carroll PR. A Randomized Study of Intraoperative Autologous Retropubic Urethral Sling on Urinary Control after Robotic Assisted Radical Prostatectomy. J Urol. 2017 02; 197(2):369-375.
    View on PubMed
  19. Leapman MS, Ameli N, Shinohara K, Nguyen HG, Meng MV, Cooperberg MR, Carroll PR. Validity of the Cancer of the Prostate Risk Assessment Score Derived From Targeted Biopsy: Modeling Evidence From Ultrasound Lesion-Directed Biopsy. Clin Genitourin Cancer. 2017 02; 15(1):93-99.
    View on PubMed
  20. Leapman MS, Clark CJ, Meng MV, Boughey JC. Diet and lifestyle can influence prostate cancer outcomes. Bull Am Coll Surg. 2016 07; 101(7):50-2.
    View on PubMed

Go to UCSF Profiles, powered by CTSI